Alnylam Pharmaceuticals shares owned by Casdin Capital
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Casdin Capital
from 13F filings
Historical chart of Casdin Capital investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alnylam Pharmaceuticals by Casdin Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $47M | 170k | 275.03 |
2024-06-30 | $41M | 170k | 243.00 |
2024-03-31 | $54M | 358k | 149.45 |
2023-12-31 | $37M | 195k | 191.41 |
2023-09-30 | $39M | 220k | 177.10 |
2023-06-30 | $53M | 280k | 189.94 |
2023-03-31 | $54M | 270k | 200.32 |
2022-12-31 | $87M | 365k | 237.65 |
2022-09-30 | $130M | 648k | 200.16 |
2022-06-30 | $117M | 805k | 145.85 |
2022-03-31 | $163M | 1.0M | 163.29 |
2021-12-31 | $170M | 1.0M | 169.58 |
2021-09-30 | $189M | 1.0M | 188.81 |
2021-06-30 | $170M | 1.0M | 169.52 |
2021-03-31 | $124M | 880k | 141.19 |
2020-12-31 | $101M | 780k | 129.97 |
2020-09-30 | $90M | 620k | 145.60 |
2020-06-30 | $82M | 550k | 148.11 |
2020-03-31 | $64M | 585k | 108.85 |
2019-12-31 | $59M | 515k | 115.17 |
2019-09-30 | $48M | 600k | 80.42 |
2019-06-30 | $47M | 650k | 72.56 |
2019-03-31 | $42M | 445k | 93.45 |
2018-12-31 | $26M | 355k | 72.91 |
2018-09-30 | $24M | 270k | 87.52 |
2018-06-30 | $27M | 270k | 98.49 |
2018-03-31 | $30M | 250k | 119.10 |
2017-12-31 | $25M | 200k | 127.05 |
2017-09-30 | $24M | 200k | 117.49 |
2017-06-30 | $8.4M | 105k | 79.76 |
2017-03-31 | $2.8M | 55k | 51.25 |
2016-12-31 | $3.2M | 85k | 37.44 |
2016-09-30 | $2.6M | 39k | 67.77 |
2016-06-30 | $4.0M | 73k | 55.49 |
2016-03-31 | $5.6M | 90k | 62.77 |
2015-12-31 | $5.6M | 60k | 94.13 |